schizophrenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Between 18 and 60 years old; 2) with a confirmed diagnosis of schizophrenia on the basis of a structured clinical interview for the International Classification of Disease 10th revision (ICD-10); 3) Had received antipsychotic treatment for more than six months prior to enrollment in the study; 4) Had cognitive deficits with a Montreal Cognitive Assessment (MoCA) score of lower than 26 points; 5) Intelligence quotient (IQ) more than 70 points on Wechsler Adult Intelligence Scale (WAIS) to be capable of completing the assessments and making a decision about participating in the study; 6) Had a clinically stable state to be capable of receiving the weekly group training.
Exclusion criteria
Exclusion criteria: Potential participants were excluded from the present study if: they suffered from any organic central nervous system disorders, severe somatic disorders, mental retardation, substance-related disorders, were receiving electroconvulsive therapy within 3 months of study enrollment, were receiving other cognitive-behavioral therapies, were pregnant or lactating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Medication Adherence;Psychiatric symptoms; | — |
Countries
China
Contacts
Ningxia Medical University